Advertisement
Canada markets close in 29 minutes

  • S&P/TSX

    21,870.05
    -141.67 (-0.64%)
     

  • S&P 500

    5,073.18
    +2.63 (+0.05%)
     

  • DOW

    38,481.86
    -21.83 (-0.06%)
     

  • CAD/USD

    0.7301
    -0.0019 (-0.26%)
     

  • CRUDE OIL

    82.95
    -0.41 (-0.49%)
     

  • Bitcoin CAD

    88,109.78
    -3,110.89 (-3.41%)
     

  • CMC Crypto 200

    1,387.60
    -36.50 (-2.56%)
     

  • GOLD FUTURES

    2,335.10
    -7.00 (-0.30%)
     

  • RUSSELL 2000

    1,991.31
    -11.33 (-0.57%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ

    15,715.92
    +19.28 (+0.12%)
     

  • VOLATILITY

    15.82
    +0.13 (+0.83%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6817
    -0.0019 (-0.28%)
     
MARKETS LIVE BLOG:

STOCKS SHED GAINS, TESLA SURGES DAY AFTER EARNINGS

Tesla shares jump after EV maker vows to speed up launch of more affordable models

Theratechnologies to Present at Upcoming Investor Conferences on October 29 and November 10, 2020

Theratechnologies
·1 min read

MONTREAL, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that management will be presenting at the following upcoming virtual investor conferences.

B. Riley Securities Liver Disease Therapeutics Day

  • Thursday, October 29, 2020

  • Panel discussion with Dr. Christian Marsolais, Senior Vice President and Chief Medical Officer

29th Annual Credit Suisse Healthcare Conference

  • Tuesday, November 10, 2020, 8:45 a.m. ET

  • Presentation by Paul Levesque, President and Chief Executive Officer

ADVERTISEMENT

To access the virtual events, please visit the ‘News’ section of the Company’s website. The webcast details will be posted one day before the event date.

About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.

For media inquiries:
Denis Boucher
Vice-President, Communications and Corporate Affairs
514-336-7800

For investor inquiries:
Leah Gibson
Senior Director, Investor Relations
lgibson@theratech.com
617-356-1009